Soft Tissue Sarcomas

Withrow and MacEwen's Small Animal Clinical Oncology: Fifth Edition

Volumn , Issue , 2012, Pages 356-380

  Liptak, Julius M ^a   Forrest, Lisa J ^b  

^a VCA Canada Alta Vista Animal Hospital   (Canada)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881122834     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2362-5.00021-9     Document Type: Chapter

References (238)

1. Theilen GH, Madewell BR Tumors of the skin and subcutaneous tissues. Veterinary cancer medicine 1979, Lea & Febiger, Philadelphia. G.H. Theilen, B.R. Madewell (Eds.).
2. Dorn ER Epidemiology of canine and feline tumors. J Am Anim Hosp Assoc 1976, 12:307-312.
3. Hardy WD The etiology of canine and feline tumors. J Am Anim Hosp Assoc 1976, 12:313-334.
4. Madewell BR, Theilen GH Etiology of cancer in animals. Veterinary cancer medicine 1979, 13-25. Lea & Febiger, Philadelphia. G.H. Theilen, B.R. Madewell (Eds.).
5. McCarthy PE, Hedlund CS, Veazy RS, et al. Liposarcoma associated with a glass foreign body in a dog. J Am Vet Med Assoc 1996, 209:612-614.
6. Thrall DE, Goldschmidt MH, Biery DN Malignant tumor formation at the site of previously irradiated acanthomatous epulides in four dogs. J Am Vet Med Assoc 1981, 178:127-132.
7. Johnstone PA, Laskin WB, DeLuca AM, et al. Tumors in dogs exposed to experimental intraoperative radiotherapy. Int J Radiat Oncol Biol Phys 1996, 34:853-857.
8. Barnes M, Duray P, DeLuca A, et al. Tumor induction following intraoperative radiotherapy: late results of the National Cancer Institute canine trials. Int J Radiat Oncol Biol Phys 1990, 19:651-660.
9. Sinibaldi K, Rosen H, Liu SK, et al. Tumors associated with metallic implants in animals. Clin Orthop 1976, 118:257-266.
10. McGlennon NJ, Houlton JEF, Gorman NT Synovial cell sarcoma-a review. J Small Anim Pract 1988, 29:139-152.
11. Murray JA Synovial sarcoma. Orthop Clin North Am 1977, 8:963-972.
12. Vail DM, Powers BE, Getzy DM, et al. Evaluation of prognostic factors for dogs with synovial cell sarcoma: 36 cases (1986-1991). J Am Vet Med Assoc 1994, 205:1300-1307.
13. Kim DY, Hodgin EC, Cho DY, et al. Juvenile rhabdomyosarcomas in two dogs. Vet Pathol 1996, 33:447-450.
14. Duda RB Review: Biology of mesenchymal tumors. Cancer J 1994, 7:52-62.
15. Thrall DE, Gillette EL Soft-tissue sarcomas. Semin Vet Med Surg Small Anim 1995, 10:173-179.
16. Kuntz CA, Dernell WS, Powers BE, et al. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc 1997, 21:1147-1151.
17. Ordonez NG Immunocytochemistry in the diagnosis of soft-tissue sarcomas. Cancer Bull 1993, 45:13-23.
18. Madewell BR, Munn RJ The soft tissue sarcomas: Immunohistochemical and ultrastructural distinctions. ACVIM Proc 1991, 9:717-720.
19. Ciekot P, Powers B, Withrow S, et al. Histologically low-grade, yet biologically high-grade, fibrosarcoma of the mandible and maxilla in dogs: 25 cases (1982-1991). J Am Vet Med Assoc 1994, 204:610-615.
20. Zhang P, Brooks JS Modern pathological evaluation of soft tissue sarcoma specimens and its potential role in soft tissue sarcoma research. Curr Treat Options Oncol 2004, 5:441-450.
21. Hogendoorn PC, Collin F, Daugaard S, et al. Pathology and Biology Subcommittee of the EORTC Soft Tissue and Bone Sarcoma Group. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment. Eur J Cancer 2004, 40:1644-1654.
22. Nilbert M, Engellau J Experiences from tissue microarray in soft tissue sarcomas. Acta Orthop Scand Suppl 2004, 75:29-34.
23. Dennis MM, McSporran KD, Bacon NJ, et al. Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs. Vet Pathol 2011, 48:73-84.
24. MacEwen EG, Powers BE, Macy D, et al. Soft tissue sarcomas. Small animal clinical oncology 2001, Saunders, Philadelphia. S.J. Withrow, E.G. MacEwen (Eds.).
25. Cook JL, Turk JR, Pope ER, et al. Infantile desmoid-type fibromatosis in an Akita puppy. J Am Anim Hosp Assoc 1998, 34:291-294.
26. Gwin RM, Gelatt KN, Peiffer RL Ophthalmic nodular fasciitis in the dog. J Am Vet Med Assoc 1977, 170:611-614.
27. Goldschmidt MH, Hendrick MJ Tumors of the skin and soft tissue. Tumors in domestic animals 2002, Iowa State Press, Ames, Iowa. D.J. Meuten (Ed.).
28. Goldschmidt MH, Shofer FS Skin tumors of the dog and cat 1998, Butterworth Heinemann, Oxford.
29. Chijiwa K, Uchida K, Tateyama S Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas. Vet Pathol 2004, 41:307-318.
30. Brehm D, Steinberg H, Haviland J, et al. A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog. J Am Anim Hosp Assoc 1995, 31:349-359.
31. Liggett AD, Frazier KS, Styler EL Angiolipomatous tumors in dogs and a cat. Vet Pathol 2002, 39:286-289.
32. Brodey RS, Rozel JF Neoplasms of the canine uterus, vagina, vulva: a clinicopathologic survey of 90 cases. J Am Vet Med Assoc 1967, 151:1294-1307.
33. Woolfson JM, Dulisch ML, Tams TR Intrathoracic lipoma in a dog. J Am Vet Med Assoc 1984, 185:1007-1009.
34. Anderson SM, Lippincott CL Intrathoracic lipoma in a dog. Calif Vet 1989, 43:9.
35. Umphlet RC, Vicini DS, Godshalk CP Intradural-extramedullary lipoma in a dog. Compend Contin Educ Pract Vet 1989, 11:1192.
36. McLaughlin R, Kuzma AB Intestinal strangulation caused by intra-abdominal lipomas in a dog. J Am Vet Med Assoc 1991, 199:1610-1611.
37. Plummer SB, Bunch SE, Khoo LH, et al. Tethered spinal cord and an intradural lipoma associated with a meningocele in a Manx-type cat. J Am Vet Med Assoc 1993, 203:1159-1161.
38. Head KW, Else RW, Dubielzig RR Tumors of the alimentary tract. Tumors in domestic animals 2002, Iowa State Press, Ames, Iowa. D.J. Meuten (Ed.).
39. Mayhew PD, Brockman DJ Body cavity lipomas in six dogs. J Small Anim Pract 2002, 43:177-181.
40. Gibbons SE, Straw RC Intra-abdominal lipoma in a dog. Aust Vet Pract 2003, 33:86.
41. Gleiser CA, Jardine JH, Raulston GL, et al. Infiltrating lipomas in the dog. Vet Pathol 1979, 16:623-624.
42. McChesney AE, Stephens LC, Lebel J, et al. Infiltrative lipoma in dogs. Vet Pathol 1980, 17:316-322.
43. Doige CE, Farrow CS, Presnell KR Parosteal lipoma in a dog. J Am Anim Hosp Assoc 1980, 16:87.
44. Bergman PJ, Withrow SJ, Straw RC, et al. Infiltrative lipoma in dogs: 16 cases (1981-1992). J Am Vet Med Assoc 1994, 205:322-324.
45. McEntee MC, Page RL, Mauldin GN, et al. Results of irradiation of infiltrative lipoma in 13 dogs. Vet Radiol Ultrasound 2000, 41:554-556.
46. McEntee MC, Thrall DE Computed tomographic imaging of infiltrative lipoma in 22 dogs. Vet Radiol Ultrasound 2001, 42:221-225.
47. Thomson MJ, Withrow SJ, Dernell WS, et al. Intermuscular lipomas of the thigh region in dogs: 11 cases. J Am Anim Hosp Assoc 1999, 35:165-167.
48. Kramek BA, Spackman CJA, Hayden DW Infiltrative lipoma in three dogs. J Am Vet Med Assoc 1985, 186:81-82.
49. Frazier KS, Herron AJ, Dee JF, et al. Infiltrative lipoma in a stifle joint. J Am Anim Hosp 1993, 29:81-83.
50. Baez JL, Hendrick MJ, Shofer FS, et al. Liposarcomas in dogs: 56 cases (1989-2000). J Am Vet Med Assoc 2004, 224:887-891.
51. Brennan MF, Singer S, Maki RG, et al. Soft tissue sarcoma. Cancer: Principles and practice of oncology 2008, Lippincott Williams & Wilkins, Philadelphia. R.T. DeVita, S. Hellman, S.A. Rosenberg (Eds.).
52. Chang HR, Hajdu SI, Collin C, et al. The prognostic value of histologic subtypes in primary extremity liposarcoma. Cancer 1989, 64:1514-1520.
53. Choong PFM, Pritchard DJ Common malignant soft-tissue tumors. Surgery for bone and soft-tissue tumors 1998, Lippincott-Raven, Philadelphia. M.A. Simon, D. Springfield (Eds.).
54. Bruecker KA, Withrow SJ Intestinal leiomyosarcomas in six dogs. J Am Anim Hosp Assoc 1988, 24:281.
55. Kapatkin AS, Mullen HS, Matthiesen DT, et al. Leiomyosarcoma in dogs: 44 cases (1983-1988). J Am Vet Med Assoc 1992, 201:1077-1079.
56. Callanan JJ, McCarthy GM, McAllister H Primary pulmonary artery leiomyosarcoma in an adult dog. Vet Pathol 2000, 37:663-664.
57. Miller MA, Ramos-Vara JA, Dickerson MF, et al. Uterine neoplasia in 13 cats. J Vet Diagn Invest 2003, 15:515-522.
58. Leifer CE, Peterson ME, Matus RE, et al. Hypoglycemia associated with nonislet cell tumor in 13 dogs. J Am Vet Med Assoc 1985, 186:53-55.
59. Bagley RS, Levy JK, Malarkey DE Hypoglycemia associated with intra-abdominal leiomyoma and leiomyosarcoma in six dogs. J Am Vet Med Assoc 1996, 208:69-71.
60. Sato K, Hikasa Y, Morita T, et al. Secondary erythrocytosis associated with high plasma erythropoietin concentrations in a dog with cecal leiomyosarcoma. J Am Vet Med Assoc 2002, 220:486-490.
61. Cohen M, Post GS, Wright JC Gastrointestinal leiomyosarcoma in 14 dogs. J Vet Intern Med 2003, 17:107-110.
62. Frost D, Lasota J, Miettinen M Gastrointestinal stromal tumors and leiomyomas in the dog: a histopathologic, immunohistochemical, and molecular genetic study of 50 cases. Vet Pathol 2003, 40:42-54.
63. Crawshaw J, Berg J, Sardinas JC, et al. Prognosis for dogs with nonlymphomatous, small intestinal tumors treated by surgical excision. J Am Anim Hosp Assoc 1998, 34:451-456.
64. Liu SM, Mikaelian I Cutaneous smooth muscle tumors in the dog and cat. Vet Pathol 2003, 40:685-692.
65. Larock RG, Ginn PE Immunohistochemical staining characteristics of canine gastrointestinal stromal tumors. Vet Pathol 1997, 34:303-311.
66. Maas CP, ter Haar G, van der Gaag I, et al. Reclassification of small intestinal and cecal smooth muscle tumors in 72 dogs: clinical, histologic, and immunohistochemical evaluation. Vet Surg 2007, 36:302-313.
67. Russell KN, Mehler SJ, Skorupski KA, et al. Clinical and immunohistochemical differentiation of gastrointestinal stromal tumors from leiomyosarcomas in dogs: 42 cases (1990-2003). J Am Vet Med Assoc 2007, 230:1329-1333.
68. Kerpsack SJ, Birchard SJ Removal of leiomyomas and other noninvasive masses from the cardiac region of the canine stomach. J Am Anim Hosp Assoc 1994, 30:500.
69. Kontogianni K, Demonakou M, Kavantzas N, et al. Prognostic predictors of gastrointestinal stromal tumors: a multi-institutional analysis of 102 patients with definition of a prognostic index. Eur J Surg Oncol 2003, 29:548-556.
70. Cooper BJ, Valentine BA Tumors of muscle. Tumors in domestic animals 2002, Iowa State Press, Ames, Iowa. D.J. Meuten (Ed.).
71. Kobayashi M, Sakai H, Hirata A, et al. Expression of myogenic regulating factors, myogenin and MyoD, in two canine botryoid rhabdomyosarcomas. Vet Pathol 2004, 41:275-277.
72. Russell HV, Pappo AS, Nuchtern JG, et al. Solid tumors of childhood. Cancer: principles and practice of oncology 2008, Lippincott Williams & Wilkins, Philadelphia. R.T. DeVita, S. Hellman, S.A. Rosenberg (Eds.).
73. Senior DF, Lawrence DT, Gunison C, et al. Successful treatment of botryoid rhabdomyosarcoma in the bladder of a dog. J Am Anim Hosp Assoc 1993, 29:386.
74. Block G, Clarke K, Salisbury SK, et al. Total laryngectomy and permanent tracheostomy for treatment of laryngeal rhabdomyosarcoma in a dog. J Am Anim Hosp Assoc 1995, 31:510-513.
75. Lascelles BDX, McInnes E, Dobson JM, et al. Rhabdomyosarcoma of the tongue in a dog. J Small Anim Pract 1998, 39:587-591.
76. Ueno H, Kadosawa T, Isomura H, et al. Perianal rhabdomyosarcoma in a dog. J Small Anim Pract 2002, 43:217-220.
77. Takiguchi M, Watanabe T, Okada H, et al. Rhabdomyosarcoma (botryoid sarcoma) of the urinary bladder in a Maltese. J Small Anim Pract 2002, 43:269-271.
78. Kelly WR, Wilkinson GT, Allen PW Canine angiosarcoma (lymphangiosarcoma): A case report. Vet Pathol 1981, 18:224-227.
79. Walsh K, Abbott DP Lymphangiosarcoma in two cats. J Comp Pathol 1984, 94:611-614.
80. Diessler ME, Castellano MC, Massone AR, et al. Cutaneous lymphangiosarcoma in a young dog: clinical, anatomopathological and lectin histochemical description. J Vet Med A Physiol Pathol Clin Med 2003, 50:452-456.
81. Itoh T, Mikawa K, Mikawa M, et al. Lymphangiosarcoma in a dog treated with surgery and chemotherapy. J Vet Med Sci 2004, 66:197-199.
82. Widmer WR, Carlton WW Persistent hematuria in a dog with renal hemangioma. J Am Vet Med Assoc 1990, 197:237-239.
83. Mott JCP, McAnulty JF, Darien DL, et al. Nephron sparing by partial median nephrectomy for treatment of renal hemangioma in a dog. J Am Vet Med Assoc 1996, 208:1274-1276.
84. Schoofs SH Lingual hemangioma in a puppy: a case report and literature review. J Am Anim Hosp Assoc 1997, 33:161-165.
85. Liptak JM, Dernell WS, Ehrhart EJ, et al. Retroperitoneal sarcomas in dogs: 14 cases (1992-2002). J Am Vet Med Assoc 2004, 224:1471-1477.
86. Ward H, Fox LE, Calderwood-Mays MB, et al. Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med 1994, 8:345-346.
87. Bulakowski EJ, Philibert JC, Siegel S, et al. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006). J Am Vet Med Assoc 2008, 233:122-128.
88. Wiley JL, Rook KA, Clifford CA, et al. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma. Vet Comp Oncol 2010, 8:221-233.
89. Miller MA, Ramos JA, Kreeger JM Cutaneous vascular neoplasia in 15 cats: clinical, morphologic, and immunohistochemical studies. Vet Pathol 1992, 29:329-336.
90. McAbee KP, Ludwig LL, Bergman PJ, et al. Feline cutaneous hemangiosarcoma: a retrospective study of 18 cases (1998-2003). J Am Anim Hosp Assoc 2005, 41:110-116.
91. Scavelli TD, Patnaik AK, Mehlhall CJ, et al. Hemangiosarcoma in the cat: retrospective evaluation of 31 surgical cases. J Am Vet Med Assoc 1985, 187:817-819.
92. Pool RR, Thompson KG Tumors of joints. Tumors in domestic animals 2002, Iowa State Press, Ames, Iowa. D.J. Meuten (Ed.).
93. Craig LE, Krimer PM, Cooley AJ Canine synovial myxoma: 39 cases. Vet Pathol 2010, 47(5):931-936.
94. Craig LE, Julian ME, Ferracone JD The diagnosis and prognosis of synovial tumors in dogs: 35 cases. Vet Pathol 2002, 39:66-73.
95. Fox DB, Cook JL, Kreeger JM, et al. Canine synovial cell sarcoma: a retrospective assessment of described prognostic criteria in 16 cases (1994-1999). J Am Anim Hosp Assoc 2002, 38:347-355.
96. Liptak JM, Withrow SJ, Macy DW, et al. Metastatic synovial cell sarcoma in two cats. Vet Comp Oncol 2004, 2:164-170.
97. Tilmant LL, Gorman NT, Ackerman N, et al. Chemotherapy of synovial cell sarcoma in a dog. J Am Vet Med Assoc 1986, 188:530-532.
98. Foale RD, White RA, Harley R, et al. Left ventricular myxosarcoma in a dog. J Small Anim Pract 2003, 44:503-507.
99. Briggs OM, Kirberger RM, Goldberg NB Right atrial myxosarcoma in a dog. J S Afr Vet Assoc 1997, 68:144-146.
100. Richter M, Stankeova S, Hauser B, et al. Myxosarcoma in the eye and brain in a dog. Vet Ophthalmol 2003, 6:183-189.
101. Spangler WL, Culbertson MR, Kass PH Primary mesenchymal (nonangiomatous/nonlymphomatous) neoplasms occurring in the canine spleen: anatomic classification, immunohistochemistry, and mitotic activity correlated with patient survival. Vet Pathol 1994, 31:37-47.
102. McDonald RK, Helman RG Hepatic malignant mesenchymoma in a dog. J Am Vet Med Assoc 1986, 188:1052-1053.
103. Hahn KA, Richardson RC Use of cisplatin for control of metastatic malignant mesenchymoma and hypertrophic osteopathy in a dog. J Am Vet Med Assoc 1989, 195:351-353.
104. Carpenter JL, Dayal Y, King NW, et al. Distinctive unclassified mesenchymal tumor of the digit of dogs. Vet Pathol 1991, 28:396-402.
105. Watson AD, Young KM, Dubielzig RR, et al. Primary mesenchymal or mixed-cell-origin lung tumors in four dogs. J Am Vet Med Assoc 1993, 202:968-970.
106. Robinson TM, Dubielzig RR, McAnulty JF Malignant mesenchymoma associated with an unusual vasoinvasive metastasis in a dog. J Am Anim Hosp Assoc 1998, 34:295-299.
107. Beaudry D, Knapp D, Montgomery T, et al. Hypoglycemia in four dogs with smooth muscle tumors. J Vet Intern Med 1995, 9:415-418.
108. Pletcher JM, Dalton L Botryoid rhabdomyosarcoma in the urinary bladder of a dog. Vet Pathol 1981, 18:695-697.
109. Kuwamura M, Yoshida H, Yamate J, et al. Urinary bladder rhabdomyosarcoma (sarcoma botryoides) in a young Newfoundland dog. J Vet Med Sci 1998, 60:619-621.
110. Baker-Gabb M, Hunt GB, France MP Soft tissue sarcomas and mast cell tumours in dogs: clinical behaviour and response to surgery. Aust Vet J 2003, 81:732-738.
111. Postorino NC, Berg RJ, Powers BE, et al. Prognostic variables for canine hemangiopericytoma: 50 cases (1979-1984). J Am Anim Hosp Assoc 1988, 24:501-509.
112. Spangler WL, Kass PH Splenic myeloid metaplasia, histiocytosis, and hypersplenism in the dog (65 cases). Vet Pathol 1999, 36:583-593.
113. Skorupski KA, Clifford CA, Paoloni MC, et al. CCNU for the treatment of dogs with histiocytic sarcoma. J Vet Intern Med 2007, 21:121-126.
114. LeRoith D, Clemmons D, Nissley P, et al. Insulin-like growth factors in health and disease. Ann Intern Med 1992, 116:854-862.
115. Cryer P Glucose homeostasis and hypoglycemia. Williams textbook of endocrinology 1992, Saunders, Philadelphia. J. Wilson, D. Foster (Eds.).
116. Boari A, Venturoli M, Minuto F Non-islet-cell tumor hypoglycemia in a dog associated with high levels of insulin-like growth factor II. World Small Animal Vet Assoc Cong Proc 1992, 17:678.
117. Sugiura H, Takahashi M, Katagiri H, et al. Additional wide resection of malignant soft tissue tumors. Clin Orthop 2002, 394:201-210.
118. Affolter VK, Moore PF Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. Am J Dermatopathol 2000, 22:40-48.
119. Affolter VK, Moore PF Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol 2002, 39:74-83.
120. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual 2002, Springer, New York.
121. Dernell WS, Withrow SJ, Kuntz CA, et al. Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract 1998, 13:59-64.
122. Banks TA, Straw RC, Withrow SJ, et al. Prospective study of canine soft tissue sarcoma treated by wide surgical excision: quantitative evaluation of surgical margins. Vet Cancer Soc Proc 2003, 23:21.
123. Reimer SB, Séguin B, DeCock HE, et al. Evaluation of the effect of routine histologic processing on the size of skin samples obtained from dogs. Am J Vet Res 2005, 66:500-505.
124. Ramanathan RC, A'Hern R, Fisher C, et al. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol 2001, 8:278-289.
125. Stojadinovic A, Leung DHY, Hoos A, et al. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002, 235:424-434.
126. Zagars GK, Ballo MT, Pisters PWT, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservative surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003, 97:2530-2543.
127. Zagars GK, Ballo MT, Pisters PWT, et al. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer 2003, 97:2544-2553.
128. Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 2003, 237:218-226.
129. Bacon NJ, Dernell WS, Ehrhart N, et al. Evaluation of primary re-excision after inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004). J Am Vet Med Assoc 2007, 230:548-554.
130. Chase D, Bray J, Ide A, et al. Outcome following removal of canine spindle cell tumours in first opinion practice: 104 cases. J Small Anim Pract 2009, 50:568-574.
131. McSporran KD Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas. Vet Pathol 2009, 46:928-933.
132. Stefanello D, Morello E, Roccabianca P, et al. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006). Vet Surg 2008, 37:461-465.
133. Elmslie RE, Glawe P, Dow SW Metronomic chemotherapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. J Vet Intern Med 2008, 22:1373-1379.
134. McEntee MC, Samii VF, Walsh P, et al. Postoperative assessment of surgical clip position in 16 dogs with cancer: a pilot study. J Am Anim Hosp Assoc 2004, 40:300-308.
135. Henry CJ, Stoll MR, Higginbotham ML, et al. Effect of timing of radiation initiation on post-surgical wound healing in dogs. Vet Cancer Soc Proc 2003, 23:52.
136. Forrest LJ, Chun R, Adams WM, et al. Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med 2000, 14:578-582.
137. McKnight JA, Mauldin GN, McEntee MC, et al. Radiation treatment of incompletely resected soft-tissue sarcomas in dogs. J Am Vet Med Assoc 2000, 217:205-210.
138. Graves GM, Bjorling DE, Mahaffey E Canine hemangiopericytoma: 23 cases (1967-1984). J Am Vet Med Assoc 1988, 192:99-102.
139. Atwater SW, LaRue SM, Powers BE, et al. Adjuvant radiation therapy of soft-tissue sarcomas in dogs. Vet Cancer Soc Proc 1992, 12:41.
140. Mauldin GN, Meleo KA, Burk RL Radiation therapy for the treatment of incompletely resected soft tissue sarcomas in dogs: 21 cases. Vet Cancer Soc Proc 1993, 13:111.
141. McChesney SL, Withrow SJ, Gillette EL, et al. Radiotherapy of soft tissue sarcomas in dogs. J Am Vet Med Assoc 1989, 194:60-63.
142. Hilmas DE, Gillett EL Radiotherapy of spontaneous fibrous connective-tissue sarcomas in animals. J Natl Cancer Inst 1976, 56:365-368.
143. Banks WC, Morris E Results of radiation treatment of naturally occurring animal tumors. J Am Vet Med Assoc 1975, 166:1063-1064.
144. Richardson RC, Anderson VL, Voorhees WD, et al. Irradiation-hyperthermia in canine hemangiopericytomas: Large-animal model for therapeutic response. J Natl Cancer Inst 1984, 73:1187-1194.
145. Lawrence J, Forrest L, Adams W, et al. Four-fraction radiation therapy for macroscopic soft tissue sarcomas in 16 dogs. J Am Anim Hosp Assoc 2008, 44:100-108.
146. McChesney-Gillette S, Dewhirst MW, Gillette EL, et al. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study. Int J Hyperthermia 1992, 8:309-320.
147. Brewer WG, Turrel JM Radiotherapy and hyperthermia in the treatment of fibrosarcomas in the dog. J Am Vet Med Assoc 1982, 181:146-150.
148. Thrall D, Prescott D, Samulski T, et al. Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. Int J Radiation Oncol Biol Phys 1996, 34:1087-1096.
149. Mauldin GN Soft tissue sarcomas. Vet Clin North Am Small Anim Pract 1997, 27:139-148.
150. Viglianti BL, Lora-Michiels M, Poulson JM, et al. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy. Clin Cancer Res 2009, 15:4993-5001.
151. Simon D, Ruslander DM, Rassnick KM, et al. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs. Vet Rec 2007, 160:321-326.
152. Kalnicki S, Bloomer W Radiation therapy in the treatment of bone and soft tissue sarcomas 1992, Saunders, Philadelphia.
153. MacLeod DA, Thrall DE The combination of surgery and radiation in the treatment of cancer. A review. Vet Surg 1989, 18:1-6.
154. Cheng EY, Dusenbery KE, Winters MR, et al. Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol 1996, 61:90-99.
155. Strander H, Turesson I, Cavallin-Stahl E A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol 2003, 42:516-531.
156. Rassnick KM, Moore AS, Russel DS, et al. Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma. J Vet Intern Med 2010, 24:1528-1531.
157. Skorupski KA, Rodriguez CO, Krick EL, et al. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy. Vet Comp Oncol 2009, 7:139-144.
158. Klahn SL, Kitchell BE, Dervisis NG Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma. J Am Vet Med Assoc 2011, 239:90-96.
159. Rassnick KM Medical management of soft tissue sarcomas. Vet Clin North Am Small Anim Pract 2003, 33:517-531.
160. Ogilvie GK, Reynolds HA, Richardson RC, et al. Phase II evaluation of doxorubicin for treatment of various canine neoplasms. J Am Vet Med Assoc 1989, 195:1580-1583.
161. Ogilvie GK, Powers BE, Mallinckrodt CH, et al. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 1996, 6:379-384.
162. Ogilvie GK, Obradovich JE, Elmslie RE, et al. Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc 1991, 198:1618-1621.
163. Henry CJ, Buss MS, Potter KA, et al. Mitoxantrone and cyclophosphamide combination chemotherapy for the treatment of various canine malignancies. J Am Anim Hosp Assoc 1999, 35:236-239.
164. Rassnick KM, Frimberger AE, Wood CA, et al. Evaluation of ifosfamide for treatment of various canine neoplasms. J Vet Intern Med 2000, 14:271-276.
165. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997, 350:1647-1654. Sarcoma Meta-Analysis Collaboration.
166. Komdeur R, Hoekstra HJ, van den Berg E, et al. Metastasis in soft tissue sarcomas: prognostic criteria and treatment perspectives. Cancer Metastasis Rev 2002, 21:167-183.
167. Selting KA, Powers BE, Thompson LJ, et al. Outcome of dogs with high-grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996-2004). J Am Vet Med Assoc 2005, 227:1442-1448.
168. Dernell WS, Withrow SJ, Straw RC, et al. Intracavitary treatment of soft tissue sarcomas in dogs using cisplatin in a biodegradable polymer. Anticancer Res 1997, 17:4499-4505.
169. Bostock DE, Dye MT Prognosis after surgical excision of canine fibrous connective tissue sarcomas. Vet Pathol 1980, 17:581-588.
170. Evans SM Canine hemangiopericytoma: a retrospective analysis of response to surgery and orthovoltage radiation. Vet Radiol 1987, 28:13-16.
171. Hauck M Feline injection site sarcomas. Vet Clin North Am Small Anim Pract 2003, 33:553-557.
172. Hendrick MJ, Goldschmidt MH, Shofer FS, et al. Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum. Cancer Res 1992, 52:5391-5394.
173. Hendrick MJ, Goldschmidt MH Do injection site reactions induce fibrosarcomas in cats?. J Am Vet Med Assoc 1991, 199:968.
174. Hendrick MJ, Shofer FS, Goldschmidt MH, et al. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992). J Am Vet Med Assoc 1994, 205:1425-1429.
175. Kass PH, Barnes WG, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993, 203:396-405.
176. Macy DW, Hendrick MJ The potential role of inflammation in the development of postvaccinal sarcomas in cats. Vet Clin North Am Small Anim Pract 1996, 26:103-109.
177. Lester S, Clemett T, Burt A Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982-1993). J Am Anim Hosp Assoc 1996, 32:91-95.
178. Hendrick MJ, Kass PH, McGill LD, et al. Postvaccinal sarcomas in cats. J Natl Cancer Inst 1994, 86:341-343.
179. Coyne MJ, Reeves NCP, Rosen DK, et al. Estimated prevalence of injection sarcomas in cats during 1992. J Am Vet Med Assoc 1997, 210:249-251.
180. Gober GM, Kass PH World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats. J Am Vet Med Assoc 2002, 220:1477-1482.
181. Kass PH, Spangler WL, Hendrick MJ, et al. Multicenter case-control study of risk factors associated with development of injection-site sarcomas in cats. J Am Vet Med Assoc 2003, 223:1283-1292.
182. Hendrick MJ Feline injection-site sarcomas. Cancer Invest 1999, 17:273-274.
183. Dubielzig RR, Hawkins KL, Miller PE Myofibroblastic sarcoma originating at the site of rabies vaccination in a cat. J Vet Diagn Invest 1993, 5:637-638.
184. McEntee MC, Page RL Feline injection-site sarcomas. J Vet Intern Med 2001, 15:176-182.
185. McNiel EA Vaccine-associate sarcomas in cats: a unique cancer model. Clin Orthop 2001, 382:21-27.
186. Séguin B Injection site sarcomas in cats. Clin Tech Small Anim Pract 2002, 17:168-173.
187. Morrison WB, Starr RM Injection-site Feline Sarcoma Task Force: Injection-site feline sarcomas. J Am Vet Med Assoc 2001, 218:697-702.
188. Peiffer RL, Monticello T, Bouldin TW Primary ocular sarcomas in the cat. J Small Anim Pract 1988, 29:105.
189. Dubielzig RR, Everitt J, Shadduck JA, et al. Clinical and morphologic features of post-traumatic ocular sarcomas in cats. Vet Pathol 1990, 27:62-65.
190. Hakanson N, Forrester SD Uveitis in the dog and cat. Vet Clin North Am Small Anim Pract 1990, 20:715-735.
191. Hendrick MJ, Brooks JJ Postvaccinal sarcomas in the cat: histology and immunohistochemistry. Vet Pathol 1994, 31:126-129.
192. Hendrick MJ Feline injection-site sarcomas: current studies on pathogenesis. J Am Vet Med Assoc 1998, 213:1425-1426.
193. Ellis JA, Jackson ML, Bartsch RC, et al. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats. J Am Vet Med Assoc 1996, 209:767-771.
194. Mayr B, Reifinger M, Alton K, et al. Novel p53 tumour suppressor mutations in cases of spindle cell sarcoma, pleomorphic sarcoma and fibrosarcoma in cats. Vet Res Comm 1998, 22:249-255.
195. Mayr B, Blauesnsteiner J, Edlinger A, et al. Presence of p53 mutations in feline neoplasms. Res Vet Sci 2000, 68:63-70.
196. Hershey AE, Dubielzig RR, Padilla ML, et al. Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis. Vet Pathol 2005, 42:805-811.
197. Nieto A, Sánchez MA, Martínez E, et al. Immunohistochemical expression of p53, fibroblast growth factor-b and transforming growth factor-α in feline injection-site sarcomas. Vet Pathol 2003, 40:651-658.
198. Katayama R, Huelsmeyer MK, Marr AK, et al. Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline injection-site sarcoma. Cancer Chemother Pharmacol 2004, 54:25-33.
199. Esplin DG, Bigelow M, McGill LD, et al. Fibrosarcoma at the site of a lufenuron injection in a cat. Vet Cancer Soc Newsletter 1999, 23:8.
200. Daly MK, Saba CF, Crochik SS, et al. Fibrosarcoma adjacent to the site of microchip implantation in a cat. J Feline Med Surg 2008, 10:202-205.
201. Carminato A, Vascellari M, Marchioro W, et al. Microchip-associated fibrosarcoma in a cat. Vet Dermatol 2011, 22(6):565-569.
202. Moore PF, Affolter VK Canine and feline histiocytic diseases. Textbook of veterinary internal medicine 2005, Elsevier Saunders, St Louis. S.J. Ettinger, E.C. Feldman (Eds.).
203. Heldmann E, Anderson MA, Wagner-Mann C Feline osteosarcoma: 145 cases (1990-1995). J Am Anim Hosp Assoc 2000, 36:518-521.
204. Cohen M, Wright JC, Brawner WR, et al. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of injection-site sarcomas in cats: 78 cases (1996-2000). J Am Vet Med Assoc 2001, 219:1582-1589.
205. Doddy FD, Glickman LT, Glickman NW, et al. Feline fibrosarcomas at vaccination sites and nonvaccination sites. J Comp Pathol 1996, 114:165-174.
206. Phelps HA, Kuntz CA, Milner RJ, et al. Radical excision with five-centimeter margins for treatment of feline injection-site sarcomas: 91 cases (1998-2002). J Am Vet Med Assoc 2011, 239:97-106.
207. Esplin DG, McGill LD, Meininger AC, et al. Postvaccination sarcomas in cats. J Am Vet Med Assoc 1993, 202:1245-1247.
208. Madewell BR, Griffey SM, McEntee MC, et al. Feline injection-site fibrosarcoma: an ultrastructural study of 20 tumors (1996-1999). Vet Pathol 2001, 38:196-202.
209. Couto SS, Griffey SM, Duarte PC, et al. Feline injection-site fibrosarcoma: morphologic distinctions. Vet Pathol 2002, 39:33-41.
210. Davidson EB, Gregory CR, Kass PH Surgical excision of soft tissue fibrosarcomas in cats. Vet Surg 1997, 26:265-269.
211. Hershey AE, Sorenmo KU, Hendrick MJ, et al. Prognosis for presumed feline injection-site sarcoma after excision: 61 cases (1986-1996). J Am Vet Med Assoc 2000, 216:58-61.
212. Brown NO, Patnaik AK, Mooney S, et al. Soft tissue sarcomas in the cat. J Am Vet Med Assoc 1978, 173:744-749.
213. Kahler S Collective effort needed to unlock factors related to feline injection site sarcomas. J Am Vet Med Assoc 1993, 202:1551-1554.
214. Lidbetter DA, Williams FA, Krahwinkel DJ, et al. Radical lateral body-wall resection for fibrosarcoma with reconstruction using polypropylene mesh and a caudal superficial epigastric axial pattern flap: a prospective clinical study of the technique and results in 6 cats. Vet Surg 2002, 31:57-64.
215. Romanelli G, Marconato L, Olivero D, et al. Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007). J Am Vet Med Assoc 2008, 232:1193-1199.
216. Cronin K, Page RL, Spodnick G, et al. Radiation therapy and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound 1998, 39:51-56.
217. Bregazzi VS, LaRue SM, McNiel E, et al. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone
218. Kobayashi T, Hauck ML, Dodge R, et al. Preoperative radiotherapy for injection-site sarcoma in 92 cats. Vet Radiol Ultrasound 2002, 43:473-479.
219. Eckstein C, Guscetti F, Roos M, et al. A retrospective analysis of radiation therapy for treatment of feline vaccine-associated sarcoma. Vet Comp Oncol 2009, 7:54-68.
220. Kleiter M, Tichy A, Willmann M, et al. Concomitant liposomal doxorubicin and daily palliative radiation therapy in advanced feline soft tissue sarcomas. Vet Radiol Ultrasound 2010, 51:349-355.
221. Williams LE, Banerji N, Klausner JS, et al. Establishment of two injection-site feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone. Am J Vet Res 2001, 62:1354-1357.
222. Banerji N, Li X, Klausner JS, et al. Evaluation of in vitro chemosensitivity of injection-site feline sarcoma cell lines to vincristine and paclitaxel. Am J Vet Res 2002, 63:728-732.
223. Barber LG, Sorenmo KU, Cronin KL, et al. Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma. J Am Anim Hosp Assoc 2000, 36:416-421.
224. Poirier VJ, Thamm DH, Kurzman ID, et al. Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of injection-site sarcomas in cats. J Vet Intern Med 2002, 16:726-731.
225. Spugnini EP, Baldi A, Vincenzi B, et al. Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol 2007, 59:375-381.
226. Jourdier TM, Moste C, Bonnet MC, et al. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 2003, 10:2126-2132.
227. Jahnke A, Hirschberger J, Fischer C, et al. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcoma: a phase I trial. J Vet Med A Physiol Pathol Clin Med 2007, 54:599-606.
228. Hüttinger C, Hirschberger J, Jahnke A, et al. Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial. J Gene Med 2008, 10:655-667.
229. Kent EM Use of an immunostimulant as an aid in treatment and management of fibrosarcoma in three cats. Fel Pract 1993, 21:13.
230. King GK, Yates KM, Greenlace PG, et al. The effect of acemannan immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas. J Am Anim Hosp Assoc 1995, 31:439-447.
231. Quintin-Colonna F, Devauchelle P, Fradelizi D, et al. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2. Gene Ther 1996, 3:1104-1112.
232. Giudice C, Stefanello D, Sala M, et al. Feline injection-site sarcoma: recurrence, tumour grading and surgical margin status evaluated using the three-dimensional histological technique. Vet J 2010, 186:84-88.
233. Dillon CJ, Mauldin GN, Baer KE Outcome following surgical removal of nonvisceral soft tissue sarcomas in cats: 42 cases (1992-2000). J Am Vet Med Assoc 2005, 227:1955-1957.
234. Macy DW Current understanding of vaccination site-associated sarcomas in the cat. J Feline Med Surg 1999, 1:15-21.
235. Martano M, Morello E, Buracco P Feline injection-site sarcoma: past, present and future perspectives. Vet J 2011, 1888:136-141.
236. Shaw SC, Kent MS, Gordon IK, et al. Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006). J Am Vet Med Assoc 2009, 234:376-380.
237. Scott FW, Geissinger CM Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesvirus, and calicivirus vaccine. Fel Pract 1997, 25:12.
238. Scott FW, Geissinger CM Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am J Vet Res 1999, 60:652-658.